Christopher William Peterson, PhD
Assistant Professor,  Translational Science and Therapeutics Division, Fred Hutch Cancer Center

“Bridging the Gap: Cell and Gene Therapies for Latent HIV Infection and Other Low-Antigen Diseases”
Over the past decade, Chimeric Antigen Receptor (CAR) T-cells have emerged as a potent therapy for B cell malignancies. Applying analogous antigen-specific approaches for diseases such as antiretroviral therapy (ART)-suppressed HIV-1 infection poses additional challenges. This presentation will outline our efforts to deliver supplemental antigen and enhance the potency of anti-HIV cell and gene therapies.